Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”
Canadian Journal of Cardiology · 2026-09 · 42 (9) · 2042-2044
DOI: 10.1016/j.cjca.2026.03.026 ↗Kurz gefasst
Korrektur in der Zeitschrift Canadian Journal of Cardiology, 2026-09. Verfasst von Primary Panel: und 38 weiteren Autor:innen. Beteiligte Einrichtung: University of British Columbia, Vancouver, British Columbia, Canada.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University of British Columbia, Vancouver, British Columbia, Canada.
- Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
- Peter Munk Cardiac Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
- Dalhousie University QEII Health Sciences Centre, Halifax, Nova Scotia, Canada.
- Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada.
- University of Alberta, Edmonton, Alberta, Canada.
Zitieren
APA
Primary Panel:, Virani, S., Zieroth, S., Aleksova, N., Anderson, K., Clarke, B., Ducharme, A., Ezekowitz, J. A., Foroutan, F., Giannetti, N., Jain, R., Lee, D., Lepage, S., Lyons, K., McDonald, M., McGuinty, C., Mielniczuk, L., O'Meara, E., Poon, S., …, & Ching Yip, A. M. (2026). Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”. Canadian Journal of Cardiology, 42(9), 2042-2044. https://doi.org/10.1016/j.cjca.2026.03.026
Vancouver
Primary Panel:, Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, et al. Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”. Canadian Journal of Cardiology. 2026;42(9):2042-2044. doi:10.1016/j.cjca.2026.03.026
BibTeX
@article{PrimaryPanel2026,
author = {Primary Panel:, Primary Panel: and Virani, Sean and Zieroth, Shelley and Aleksova, Natasha and Anderson, Kim and Clarke, Brian and Ducharme, Anique and Ezekowitz, Justin A and Foroutan, Farid and Giannetti, Nadia and Jain, Rahul and Lee, Douglas and Lepage, Serge and Lyons, Kristin and McDonald, Michael and McGuinty, Caroline and Mielniczuk, Lisa and O'Meara, Eileen and Poon, Stephanie and Siatecki, Kyla and Swiggum, Elizabeth and Toma, Mustafa and Turgeon, Ricky D and Review Panel:, Review Panel: and Bains, Marc and Davis, Margot K and De, Sabe and Fine, Nowell and Heshka, Jodi and Keen, Sabina and King, Alexandra and Lavoie, Andrea and Mak, Susanna and McCleary, Lynn and Outbih, Oussama and Pike, Rodolfo and Sharma, Abhinav and Van Spall, Harriette G C and Ching Yip, Amelia Ming},
title = {Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {9},
pages = {2042--2044},
doi = {10.1016/j.cjca.2026.03.026}
}
EUVIMED